Awarded
1. Bevacizumab Intravenoso
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- AMGEN, S.A., BIOCON BIOLOGICS SPAIN, S.L, Celltrion Farmaceutica España SL, CIPLA EUROPE NV Sucursal en España, LABORATORIO STADA SL, ORGANON SALUD, S.L., PFIZERSLU
- Contract value
- no value published
- Bids received
- 7
- Published
- 5 Jun 2026
- Awarded
- 29 May 2026
- Contract start
- 29 May 2026
- Contract end
- 16 Jun 2027estimated
- Region
- Tenerife